The impact of age on survival of diffuse large B-cell lymphoma – a population-based study

Abstract

This is one of the largest population-based studies of DLBCL published to date. In this study, age persisted as a significant adverse risk factor for patients as young as 40 years, even after adjustment for other risk factors.